| Step 1 | Step 1 Unknown | Step 1 EPHA2− | Step 1 EPHA2+ | Step 1 EPHA22+ | Step 1 EPHA23+ | Step 2 | Step 2 EPHA2− | Step 2 EPHA2+ | Step 2 EPHA22+ | Step 2 EPHA23+ |
---|---|---|---|---|---|---|---|---|---|---|---|
(N = 21) | (N = 3) | (N = 9) | (N = 2) | (N = 6) | (N = 1) | (N = 15) | (N = 0) | (N = 0) | (N = 13) | (N = 2) | |
 | N (%) [95% CI] | N (%) [95% CI] | N (%) [95% CI] | N (%) [95% CI] | N (%) [95% CI] | N (%) [95% CI] | N (%) [95% CI] | N (%) [95% CI] | N (%) [95% CI] | N (%) [95% CI] | N (%) [95% CI] |
Complete response | 0 (0.0) [0.0–16.1] | 0 (0.0) [0.0–70.8] | 0 (0.0) [0.0–33.6] | 0 (0.0) [0.0–84.2] | 0 (0.0) [0.0–45.9] | 0 (0.0) [0.0–97.5] | 0 (0.0) [0.0–21.8] | 0 (0.0) [n.d.] | 0 (0.0) [n.d.] | 0 (0.0) [0.0–24.7] | 0 (0.0) [0.0–84.2] |
Partial response | 0 (0.0) [0.0–16.1] | 0 (0.0) [0.0–70.8] | 0 (0.0) [0.0–33.6] | 0 (0.0) [0.0–84.2] | 0 (0.0) [0.0–45.9] | 0 (0.0) [0.0–97.5] | 1 (6.7) [0.2–31.9] | 0 (0.0) [n.d.] | 0 (0.0) [n.d.] | 1 (7.7) [0.2–36.0] | 0 (0.0) [0.0–84.2] |
Stable disease | 7a (33.3) [14.6–57.0] | 2 (66.7) [9.4–99.2] | 3 (33.3) [7.5–70.1] | 1 (50.0) [1.3–98.7] | 1 (16.7) [0.4–64.1] | 0 (0.0) [0.0–97.5] | 6 (40.0) [16.3–67.7] | 0 (0.0) [n.d.] | 0 (0.0) [n.d.] | 5 (38.5) [13.9–68.4] | 1 (50.0) [1.3–98.7] |
Progressive disease | 14a (66.7) [43.0–85.4] | 1 (33.3) [0.8–90.6] | 6 (66.7) [29.9–92.5] | 1 (50.0) [1.3–98.7] | 5 (83.3) [35.9–99.6] | 1 (100.0) [2.5–100.0] | 8 (53.3) [26.6–78.7] | 0 (0.0) [n.d.] | 0 (0.0) [n.d.] | 7 (53.8) [25.1–80.8] | 1 (50.0) [1.3–98.7] |